Charles T. Nomides

Charles T.
Nomides was appointed Chief Research and Development Officer for Barrier Therapeutics, Inc. in February 2006.
From July 2002 to February 2006, he served as Chief Operating Officer of Barrier Therapeutics.
From 1997 to 2002, he was employed by Johnson & Johnson Consumer Products Worldwide, where he served as Director of Research and Development in charge of the Ortho Neutrogena Prescription Drug Development Group.
Mr. Nomides received a Bachelor's degree in Biology from Clarion State University and graduate training from Temple University and The Milton S.
Hershey Medical Center.